| Varespladib | IC50 | 12.0 [1] |
| (3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid | IC50 | 470.0 [1] |
| Manoalide | IC50 | 3900.0 [1], 93200.0 [2], 1500000.0 [3] |
| 2-(1-Benzyl-5-methoxy-2-methyl-1h-indol-3-yl)acetamide | IC50 | 540.0 [1], 840.0 [2], 880.0 [3], 1000.0 [4] |
| 1,2,4-Oxadiazol-5(2H)-one, 3-[[4-(tetradecyloxy)phenyl]methyl]- | IC50 | 3400.0 [1], 4000.0 [2] |
| 2-(3-(2-Amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)propanoic acid | IC50 | 11.0 [1], 13.0 [2], 170.0 [3] |
| Me-indoxam | IC50 | 3.0 [1], 6.0 [2], 180.0 [3] |
| ((3-(2-Amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)acetic acid | IC50 | 11.0 [1], 19.0 [2], 275.0 [3] |
| 4-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-butyric acid | IC50 | 189.0 [1], 13500.0 [2], 94000.0 [3] |
| 4-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-butyric acid | IC50 | 399.0 [1], 610.0 [2], 3660.0 [3] |
| 2-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxymethyl)-benzoic acid | IC50 | 147.0 [1], 7500.0 [2], 22500.0 [3] |
| (1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-acetic acid | IC50 | 52.0 [1], 150.0 [2], 1400.0 [3] |
| 3-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-propane-1-sulfonic acid | IC50 | 50.0 [1], 5800.0 [2], 135000.0 [3] |
| 4-(1-Benzyl-2-bromo-3-carbamoylmethyl-6-chloro-1H-indol-5-yloxy)-butyric acid | IC50 | 20.0 [1], 1300.0 [2], 3200.0 [3] |
| 4-(1-Benzyl-2-bromo-3-carbamoylmethyl-1H-indol-5-yloxy)-butyric acid | IC50 | 73.0 [1], 2860.0 [2], 15900.0 [3] |
| [3-(1-Benzyl-2-bromo-3-carbamoylmethyl-1H-indol-5-yloxy)-propyl]-phosphonic acid | IC50 | 33.0 [1], 2200.0 [2], 6200.0 [3] |
| (1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-4-yloxy)-acetic acid | IC50 | 24.0 [1], 130.0 [2], 1800.0 [3] |
| (1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxymethyl)-phosphonic acid | IC50 | 1290.0 [1], 5550.0 [2], 73500.0 [3] |
| [3-(1-Biphenyl-2-ylmethyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-propyl]-phosphonic acid | IC50 | 22.0 [1], 7600.0 [2], 39000.0 [3] |
| 4-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-butyric acid | IC50 | 152.0 [1], 25000.0 [2], 69000.0 [3] |
| [3-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-propyl-]-phosphonic acid | IC50 | 57.0 [1], 27000.0 [2], 67000.0 [3] |
| Sodium;2-[3-(2-amino-2-oxoethyl)-1-[(3-chlorophenyl)methyl]-2-methylindol-4-yl]oxyacetate | IC50 | 20.0 [1], 52.0 [2], 1200.0 [3] |
| Sodium;2-[3-(2-amino-2-oxoethyl)-2-methyl-1-[(2-phenylphenyl)methyl]indol-4-yl]oxyacetate | IC50 | 10.0 [1], 14.0 [2], 4090.0 [3] |
| Cacospongionolide B | IC50 | 4300.0 [1], 86700.0 [2] |
| 5-Benzyloxy-DL-tryptophan | IC50 | 42100.0 [1] |
| 4-(3,5-Didodecanoyl-2,4,6-trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman | IC50 | 80.0 [1], 1000.0 [2] |
| 2-[(1-Benzyl-2-methyl-3-oxamoyl-7,8-dihydro-6H-cyclopenta[g]indol-4-yl)oxy]acetic acid | IC50 | 6.0 [1], 10.0 [2] |
| 4-Methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetamide | IC50 | 1180.0 [1], 2360.0 [2] |
| 2-(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)-2-oxo-acetamide | IC50 | 1230.0 [1], 2560.0 [2] |
| Spla2-X inhibitor 31 | IC50 | 310.0 [1] |
| 3-{4-[(4-Octadecylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one | IC50 | 5080.0 [1] |
| 3-({4-[(4-Octadecylpiperazin-1-yl)methyl]phenyl}methyl)-4,5-dihydro-1,2,4-oxadiazol-5-one | IC50 | 2200.0 [1] |
| 3-({4-[(4-Octadecylpiperazin-1-yl)carbonyl]phenyl}methyl)-4,5-dihydro-1,2,4-oxadiazol-5-one | IC50 | 800.0 [1] |
| Cacospongionolide E | IC50 | 1400.0 [1], 96700.0 [2] |
| 2-[(1-Benzyl-2-ethyl-3-oxamoyl-6,7,8,9-tetrahydrobenzo[g]indol-4-yl)oxy]acetic acid | IC50 | 11.0 [1], 17.0 [2] |
| 2-[[3-(2-Amino-1,2-dioxoethyl)-1-cyclohexylmethyl-2-methyl-1H-benz[g]indol-4-yl]oxy]acetic acid | IC50 | 4.0 [1], 11.0 [2] |
| 2-[(1-Benzyl-2-methyl-3-oxamoyl-6,7,8,9-tetrahydrobenzo[g]indol-4-yl)oxy]acetic acid | IC50 | 10.0 [1], 16.0 [2] |
| 2-[(1-Benzyl-2-ethyl-3-oxamoyl-7,8-dihydro-6H-cyclopenta[g]indol-4-yl)oxy]acetic acid | IC50 | 7.0 [1], 13.0 [2] |
| 2-[1-[(2-Benzylphenyl)methyl]-2-ethyl-3-oxamoylindol-4-yl]oxyacetic acid | IC50 | 4.0 [1] |
| 2-(2-Methyl-1-octyl-3-oxamoylindol-4-yl)oxyacetic acid | IC50 | 8.0 [1], 18.0 [2] |
| (2S)-2-(1-Benzyl-2-methyl-3-oxamoylindol-4-yl)oxypropanoic acid | IC50 | 136.0 [1], 188.0 [2] |
| 2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)oxy-4-phenylbutanoic acid | IC50 | 26.0 [1], 46.0 [2] |
| 2-(1-Benzoyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid | IC50 | 39.0 [1], 81.0 [2] |
| (2R)-2-(1-Benzyl-2-methyl-3-oxamoylindol-4-yl)oxypropanoic acid | IC50 | 6.0 [1], 11.0 [2] |
| 2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)sulfanylacetic acid | IC50 | 145.0 [1], 210.0 [2] |
| 2-[1-[(2-Chlorophenyl)methyl]-2-methyl-3-oxamoylindol-4-yl]oxyacetic acid | IC50 | 9.0 [1], 25.0 [2] |
| 2-(1-Benzyl-2-ethyl-3-oxamoylindol-4-yl)oxy-2-methylpropanoic acid | IC50 | 25.0 [1], 29.0 [2] |
| 2-[2-Methyl-1-[(2-methylphenyl)methyl]-3-oxamoylindol-4-yl]oxyacetic acid | IC50 | 15.0 [1], 45.0 [2] |
| 2-[4-[2-(Benzenesulfonamido)-2-oxoethoxy]-1-benzyl-2-methyl-6,7,8,9-tetrahydrobenzo[g]indol-3-yl]-2-oxoacetamide | IC50 | 3.0 [1], 7.0 [2] |
| 3-[4-(3-Phenylmethoxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one | IC50 | 14800.0 [1], 100000.0 [2] |
| 3-[4-(3-Decoxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one | IC50 | 280.0 [1], 1000.0 [2] |
| 3-[4-[3-(4-Phenylbutoxy)-2-tetradecoxypropoxy]phenyl]-4H-1,2,4-oxadiazol-5-one | IC50 | 290.0 [1], 26000.0 [2] |
| 3-[4-(3-Benzhydryloxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one | IC50 | 280.0 [1], 5000.0 [2] |
| 3-[4-(2-Tetradecoxy-3-trityloxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one | IC50 | 900.0 [1], 2000.0 [2] |
| 4-[[3-[4-[(5-Oxo-4H-1,2,4-oxadiazol-3-yl)methyl]phenoxy]-2-tetradecoxypropoxy]methyl]benzonitrile | IC50 | 1100.0 [1], 7600.0 [2] |
| 4-[[2-Octadecoxy-3-[4-[(5-oxo-4H-1,2,4-oxadiazol-3-yl)methyl]phenoxy]propoxy]methyl]benzonitrile | IC50 | 150.0 [1], 1150.0 [2] |
| Cacospongionolide | IC50 | 3000.0 [1], 90700.0 [2] |
| 2-(1-Benzyl-2-ethyl-6-methyl-3-oxamoylindol-4-yl)acetic acid | IC50 | 8.0 [1] |
| 2-[[3-(2-Amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]propanoic acid | IC50 | 9.0 [1], 10.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)1-[(3-chlorophenyl)methyl]-2-ethyl-1H-indol-4-yl]oxy]acetic acid | IC50 | 7.0 [1], 25.0 [2] |
| 2-[2-Cyclopropyl-3-oxamoyl-1-[(2-phenylphenyl)methyl]indol-4-yl]oxyacetic acid | IC50 | 6.0 [1], 23.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)-1-[(4-fluorophenyl)methyl]-2-methyl-1H-indol-4-yl]oxy]acetic acid | IC50 | 30.0 [1], 74.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)-1-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-1H-indol-4-yl]oxy]acetic acid | IC50 | 43.0 [1], 150.0 [2] |
| 2-[2-Methyl-1-(naphthalen-1-ylmethyl)-3-oxamoyl-indol-4-yl]oxyethanoic acid | IC50 | 9.0 [1], 17.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)1-[(2,6-dichlorophenyl)methyl]-2-methyl-1H-indol-4-yl]oxy]acetic acid | IC50 | 6.0 [1], 22.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)-2-cyclopropyl-1-(phenylmethyl)-1H-indol-4-yl]oxy)acetic acid | IC50 | 28.0 [1], 41.0 [2] |
| ((3-(2-Amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2-methyl-1H-indol-4-yl)oxy)acetic acid | IC50 | 8.0 [1], 9.0 [2] |
| [[3-(2-Amino-1,2-dioxoethyl)-1-([1,1'-biphenyl]-2-ylmethyl)-2-ethyl-1H-indol-4-yl]oxy]acetic acid | IC50 | 6.0 [1] |
| Quinacrine | IC50 | 76000000.0 [1] |
| Ubenimex | IC50 | 100000.0 [1] |
| Zileuton | IC50 | 1000000.0 [1] |
| Phenidone | IC50 | 1000000.0 [1] |
| Amentoflavone | IC50 | 23800.0 [1] |
| Scalaradial | IC50 | 15.0 [1] |
| Indoxam | IC50 | 60.0 [1] |
| Bolinaquinone | IC50 | 200.0 [1] |
| Ochnaflavone | IC50 | 3500.0 [1] |
| 4-(s)-[(1-Oxo-7-phenylheptyl)amino]-5-[4-(phenylmethyl)phenylthio]pentanoic acid | IC50 | 21.0 [1] |
| N,N-Diethylhexadecane-1,2-diamine | IC50 | 5600.0 [1] |
| 4',7-Flavandiol | IC50 | 3300.0 [1] |
| 2-(Ethylamino)-1-hexadecanol | IC50 | 3700.0 [1] |
| Dysidine | IC50 | 2000.0 [1] |
| N-Hexadecanoyl-leucine | IC50 | 1660.0 [1] |
| 7-Benzyloxytryptamine | IC50 | 52500.0 [1] |
| 3-[(1E,3Z,5E,7E)-1-Carboxy-2,6-dimethyl-8-(2,6,6-trimethylcyclohexen-1-yl)octa-1,3,5,7-tetraen-3-yl]benzoic acid | IC50 | 40000.0 [1] |
| 6-(4-Oxo-2-phenyl-chromen-6-yl)-2-phenyl-chromen-4-one | IC50 | 69300.0 [1] |
| Didodecanoylphloroglucinol | IC50 | 1600.0 [1] |
| 2-(1-Benzyl-6-methoxy-2-methyl-1H-indol-3-yl)-2-hydroxy-acetamide | IC50 | 120900.0 [1] |
| 2-(4-Phenoxyphenoxy)ethanamine | IC50 | 7300.0 [1] |
| 2-{4-[4-(4-Oxo-4H-chromen-2-yl)phenyl]phenyl}-4H-chromen-4-one | IC50 | 3000.0 [1] |
| N-(Carboxymethyl)-N-(3,5-bis(decyloxy)-phenyl)glycine | IC50 | 230.0 [1] |
| 6-[3-(4-Oxo-4H-chromen-2-yl)-phenyl]-2-phenyl-chromen-4-one | IC50 | 19900.0 [1] |
| 5-Benzyloxytryptamine hydrochloride | IC50 | 52000.0 [1] |
| 2-{4-[3-(4-Oxo-4H-chromen-2-yl)phenyl]phenyl}-4H-chromen-4-one | IC50 | 15500.0 [1] |
| 6-[4-(4-Oxo-4H-chromen-2-yl)-phenyl]-2-phenyl-chromen-4-one | IC50 | 63900.0 [1] |
| 3-(4-(4-Oxo-4H-chromen-2-yl)phenyl)-2-phenyl-4H-chromen-4-one | IC50 | 23200.0 [1] |
| (S)-4-Methyl-2-(2-oxohexadecanamido)pentanoic acid | IC50 | 300.0 [1] |
| Methyl 6-methoxy-2-(2-phenylethyl)quinoline-4-carboxylate | IC50 | 1500.0 [1] |
| 2-[2-Ethyl-3-oxamoyl-1-(phenylmethyl)benzo[g]indol-4-yl]oxyacetic acid | IC50 | 40.0 [1] |
| 1-[2-(2-Methyl-4-carboxyphenoxy)ethyl]-3-dodecanoyl-1H-indole-2-carboxylic acid | IC50 | 570.0 [1] |